Center for Development and Behavioral Neuroscience, Department of Psychology, Binghamton University, Binghamton, NY 13902-6000, USA.
Pharmacol Biochem Behav. 2013 Aug;109:31-7. doi: 10.1016/j.pbb.2013.05.004. Epub 2013 May 8.
The partial α2,3,5 GABA(A) receptor agonist, L-838,417 has been reported to have anxiolytic effects in adult rodents. Although maturational differences exist for the GABA(A) receptor subunits, the anxiolytic effects of L-838,417 have not been tested in younger animals. The goal of the present experiments was to determine whether L-838,417 reverses anxiety-like behavior induced by either an unfamiliar environment (Experiment 1) or repeated restraint stress (Experiment 2) differentially in adolescent and adult, male and female Sprague-Dawley rats using a modified social interaction test. In Experiment 1, rats were injected with 0, 0.5, 1.0, 2.0, or 4.0 mg/kg L-838,417, i.p. and tested 30 min later in an unfamiliar test context for 10 min. In Experiment 2, rats were exposed to restraint stress (90 min daily for 5 days). Immediately after the last restraint session, animals were injected with L-838,417 and placed alone for 30 min in the test apparatus to familiarize them to this context prior to the 10 min social interaction test. In Experiment 1, L-838,417 produced anxiolytic effects in adults at 1.0 mg/kg, as indexed by a transformation of social avoidance into preference and an increase in social investigation. In adolescents, a dose of 2.0 mg/kg eliminated social avoidance, but had no anxiolytic effects on social investigation. Testing under familiar circumstances (Experiment 2) after repeated restraint stress eliminated age differences in sensitivity to L-838,417, with 0.5 mg/kg reversing the anxiogenic effects of prior stress regardless of age, but with doses ≥ 1 mg/kg decreasing social investigation, an effect possibly due in part to locomotor-impairing effects of this compound. Although locomotor activity was suppressed in both experiments, higher doses of L-838,417 were necessary to suppress locomotor activity in Experiment 1. Thus, anxiolytic effects of L-838,417 were found to be context-, age-, and stress-dependent.
部分α2,3,5 GABA(A) 受体激动剂 L-838,417 已被报道在成年啮齿动物中具有抗焦虑作用。尽管 GABA(A) 受体亚基存在成熟差异,但 L-838,417 的抗焦虑作用尚未在年幼动物中进行测试。本实验的目的是确定 L-838,417 是否能在改良的社交互动测试中,以不同的方式逆转由陌生环境(实验 1)或重复束缚应激(实验 2)诱导的焦虑样行为,分别在青少年和成年雄性和雌性 Sprague-Dawley 大鼠中。在实验 1 中,大鼠腹腔注射 0、0.5、1.0、2.0 或 4.0 mg/kg L-838,417,30 分钟后在陌生测试环境中测试 10 分钟。在实验 2 中,大鼠暴露于束缚应激(每天 90 分钟,共 5 天)。最后一次束缚后,立即给动物注射 L-838,417,并将它们单独放置在测试仪器中 30 分钟,使它们熟悉这个环境,然后进行 10 分钟的社交互动测试。在实验 1 中,L-838,417 在 1.0 mg/kg 时在成年大鼠中产生抗焦虑作用,表现为社交回避转化为偏好,并增加社交探索。在青少年中,2.0 mg/kg 的剂量消除了社交回避,但对社交探索没有抗焦虑作用。在重复束缚应激后的熟悉环境下测试(实验 2)消除了对 L-838,417 的敏感性的年龄差异,0.5 mg/kg 逆转了先前应激的焦虑作用,而无论年龄大小,剂量≥1 mg/kg 均减少了社交探索,这一作用可能部分归因于该化合物的运动障碍作用。尽管在两个实验中都抑制了运动活动,但在实验 1 中需要更高剂量的 L-838,417 来抑制运动活动。因此,L-838,417 的抗焦虑作用取决于环境、年龄和应激。